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Abstract
Background—Patients with post-traumatic stress disorder (PTSD) are at increased risk for
adverse outcomes from comorbid medical conditions. Medication non-adherence is a potential
mechanism explaining this increased risk.
Methods—We examined the association between PTSD and medication adherence in a cross-
sectional study of 724 patients recruited from two Department of Veterans Affairs Medical
Centers between 2008 and 2010. PTSD was assessed using the Clinician Administered PTSD
Scale. Medication adherence was assessed using a standardized questionnaire. Ordinal logistic
regression models were used to calculate the odds ratios (ORs) for medication non-adherence in
patients with versus without PTSD, adjusting for potential confounders.
Results—A total of 252 patients (35%) had PTSD. Twelve percent of patients with PTSD
reported not taking their medications as prescribed compared to 9% of patients without PTSD
(unadjusted OR 1.85, 95% CI 1.37–2.50, P<.001). Forty-one percent of patients with PTSD
compared to 29% of patients without PTSD reported forgetting medications (unadjusted OR 1.90,
95%CI 1.44 – 2.52, P<.001). Patients with PTSD were also more likely to report skipping
medications (24% versus 13%; unadjusted OR 2.01, 95% CI 1.44–2.82, P<.001). The association
between PTSD and non-adherence remained significant after adjusting for demographics,
depression, alcohol use, social support, and medical comorbidities (adjusted OR 1.47, 95% CI
1.03–2.10, P=0.04 for not taking medications as prescribed and 1.95, 95% CI 1.31–2.91, P=.001
for skipping medications).
Conclusions—PTSD was associated with medication non-adherence independent of psychiatric
and medical comorbidities. Medication non-adherence may contribute to the increased morbidity
and mortality observed in patients with PTSD.
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INTRODUCTION
Post-traumatic stress disorder (PTSD) is a common, typically chronic anxiety disorder with
a prevalence of 8–12% in the general population and 13–31% in veterans.[1–5] PTSD
comes at a profound cost in terms of disabling psychological distress, elevated risk for
suicide, and inability to work.[6] A growing body of research also demonstrates that PTSD,
in both veterans and civilians, increases the risks and consequences associated with
comorbid medical conditions.[7–13] For example, patients with PTSD are at increased risk
of recurrent cardiovascular events,[14, 15] and among patients with diabetes, those with
PTSD have poorer glycemic control and worse prognosis.[16, 17] The mechanisms
explaining the associations between PTSD and adverse outcomes from medical illness
remain poorly understood.[18]
Medication adherence represents one of the most essential health behaviors for preventing
complications from medical conditions. While some studies have shown that individuals
with PTSD engage in increased smoking[19] and decreased physical activity[20], far less is
known about the impact of PTSD on medication-taking behavior. Studies that have
examined medication adherence in PTSD thus far have restricted their analysis to
populations with specific medical illnesses that may directly induce PTSD, including acute
coronary events and HIV diagnosis.[15, 21] PTSD that develops related to myocardial
infarction or HIV may have different associations with medication non-adherence than
PTSD due to more general types of traumatic events.
Accordingly, we sought to better understand the relationship between PTSD and medication
adherence in a group of outpatients recruited without regard to specific disease status or
trauma exposure. We hypothesized that patients with PTSD would have lower rates of
medication adherence, even after accounting for depression and other potential confounders.
METHODS
Patients
The Mind Your Heart Study is a prospective cohort study designed to examine the
association between PTSD and health outcomes. Patients were recruited between February
2008 and June 2010 from outpatient clinics affiliated with two Department of Veterans
Affairs (VA) Medical Centers (San Francisco VA Medical Center and the VA Palo Alto
Health Care System, California). Patients were excluded if they planned on leaving the area
in three years or did not have contact information for follow-up. Potential patients were also
excluded if they were unable to walk one block or had a myocardial infarction in the prior
six months as a cardiac treadmill test was done for the study and would be contraindicated in
these cases. All patients provided written informed consent and appropriate institutional
review boards approved the research protocol.
Overall, 1,020 patients were assessed for eligibility. One hundred and four patients (10.2%)
were found ineligible, primarily due to lacking contact information for follow-up (n=82). Of
the remaining 916 eligible patients, 172 (18.8%) declined to participate or did not show up
for the baseline interview such that 744 patients were ultimately enrolled in the study. Ten
patients were excluded from these analyses because they did not complete full PTSD
assessments or because the supervising study psychologist had concerns about the accuracy
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of the PTSD diagnosis. Another 10 patients were excluded because they reported not taking
any medications, leaving 724 patients for these analyses.
PTSD
We evaluated PTSD with the Clinician Administered PTSD Scale (CAPS) using criteria
from the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV).[22] The
CAPS is the most widely used structured interview for diagnosing PTSD [23, 24] and has
excellent test-retest reliability (r=0.92–0.99) and internal consistency (alpha= 0.80–0.90).
[24] The CAPS was also used to identify the categories of trauma exposure that were
common in patients with PTSD.
Medication Adherence
We assessed medication adherence using a standardized questionnaire based on the one used
to measure adherence in the CARDIA (Coronary Artery Risk Development in Young
Adults) study.[25, 26] Cut-points for determining whether someone was non-adherent were
chosen according to convention.[25] Overall medication adherence was assessed by asking
patients “Overall, in the past month, how often did you take your medications as the doctor
prescribed?” Possible responses were less than half of the time, about half of the time, most
of the time, nearly all of the time, and all of the time; overall non-adherence was defined as
taking medication as prescribed half of the time or less. Forgetting to take medications was
assessed by asking “In the past month, how often did you forget to take one or more of your
prescribed medications?” Possible responses were never, once in the last month, 2 to 3 times
in the last month, about once per week, several times per week, or nearly every day; non-
adherence was defined as forgetting medications once per week or more. Deciding not to
take medications was evaluated with the question “In the past month, how often did you
decide to skip one or more of your medications?” Possible responses were never, once in the
last month, 2 to 3 times in the last month, about once per week, several times per week, or
nearly every day; non-adherence was defined as skipping medications once per week or
more.
Covariates
We administered a self-report questionnaire to all patients to determine age, sex, ethnicity,
income, education, and medical history.[27] We used the Alcohol Use Disorders
Identification Test-consumption questions (AUDIT-C), a validated screening questionnaire,
to measure alcohol use, and used recommended cut-off scores of 3 for women and 4 for men
to identify patients with possible problematic alcohol use.[28, 29] We assessed social
support with the validated 12-item Multidimensional Scale of Perceived Social Support
(MSPSS).[30, 31] We used the 9-item Patient Health Questionnaire (PHQ-9) to evaluate
depressive symptoms. This self-report instrument measures the frequency of depressive
symptoms corresponding to the 9 symptom criteria in the DSM-IV. A standard cut-point of
≥10 is used to define depression and has demonstrated excellent validity when compared
with a mental health interview with a sensitivity of 88% and a specificity of 88%.[32]
Statistical Analysis
We compared differences in characteristics between patients with and without PTSD using t
tests or Mann-Whitney U tests for continuous variables and chi-square tests for dichotomous
variables. Given the ordinal nature of our medication adherence variables, for our main
analyses, we used separate ordinal logistic regression models to evaluate the association of
PTSD with the three medication adherence outcomes. These models yield single odds ratios
for the association of the predictor variable (PTSD) with each combination of higher versus
lower-risk outcome categories (for example, skipping medications nearly every day vs. other
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categories; nearly every day or several times per week vs. other categories; nearly every day,
several times per week, or about once per week vs. other categories; etc.). We adjusted for
patient characteristics from Table 1 that were associated with PTSD at P<.20 using staged
models. Covariates included in the final models included sex, depression, alcohol use, social
support, and history of hypertension, elevated cholesterol, diabetes, myocardial infarction, or
chronic obstructive pulmonary disease. The proportional odds assumption was verified for
all models. To determine if there were differences in the strength of the association between
PTSD and type of non-adherence (forgetting to take and deciding to skip medications), we
transformed the odds ratios for the association between PTSD and non-adherence into r-
scores and then derived a Z-statistic according to the method recommended by Steiger.[33]
For our secondary analyses, we used the pre-defined cut-points to determine whether
patients were or were not adherent and then used chi-squared to test for differences in the
proportion of patients with and without PTSD who were non-adherent. All statistical tests
were two-sided with α=0.05. We used Stata version 11 (StataCorp; College Station, Texas)
to perform all analyses.
RESULTS
Of the 724 patients analyzed, 251 (35%) had PTSD. The mean age of patients was 58 years,
6% were women, and 58% self-identified their race as white. Among patients with PTSD,
the most common types of trauma exposures were combat-related (55%), sexual assault
(12%), physical assault (8%), non-combat military trauma (3%), accident (2%), and
unexpected death of close friend or relative (2%). Compared to patients without PTSD,
those with PTSD were more likely (P <0.05) to be female, to have depression, to have lower
social support, and to have at-risk alcohol use (Table 1). Patients with PTSD also had higher
rates of several comorbid chronic medical conditions.
In unadjusted analyses, patients with PTSD had nearly twice the odds of not taking their
medications as prescribed as compared to patients without PTSD (Table 2). The association
between PTSD and this measure of medication adherence remained significant even after
controlling for potential confounders, including demographics, depression, alcohol use, and
medical comorbidities (adjusted OR for overall decreased adherence 1.47, 95% CI 1.03 –
2.10; P =0.04).
As compared to patients without PTSD, patients with PTSD were also more likely to report
forgetting their medications and skipping their medications (Figure). In fully adjusted
regression analyses, there was a stronger association between PTSD and deciding to skip
medications (adjusted OR 1.95, 95% CI 1.31–2.91; P =0.001) as compared to PTSD and
forgetting medications (adjusted OR 1.32, 95% CI 0.95 – 1.83; P =0.09), and the difference
in these adjusted ORs was statistically significant (P<0.001).
CONCLUSIONS
We found that PTSD was associated with lower medication adherence in our sample of 724
patients, even after controlling for depression and other potential confounders. In addition,
we found that patients with PTSD were more likely to report forgetting and deciding to skip
their medications. This establishes PTSD as an independent risk factor for medication non-
adherence in patients recruited from general medicine clinics and expands upon prior studies
in this area.
Prior investigators have shown that PTSD was associated with lower adherence to
medications prescribed for specific medical illnesses. For example, Shemesh and colleagues
enrolled 73 patients with a recent history of myocardial infarction and reported that patients
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with PTSD had a higher prevalence of medication non-adherence than patients without
PTSD.[15] This analysis, however, was limited by its small sample size and was not
adjusted for depression or other potential confounders. In a larger sample, Zen and
colleagues showed that PTSD was associated with decreased medication adherence in
patients with stable coronary heart disease, however this association did not remain
significant after adjusting for depression.[20] PTSD has also been associated with decreased
adherence in patients with HIV, but the comorbidity between PTSD and depression was so
high in one study that investigators were unable to test whether PTSD was associated with
non-adherence independent of depression.[34] In contrast, our study examines the
association between PTSD and medication adherence in a broad group of outpatients
without any specific medical illnesses and includes sufficient patients without comorbid
depression to test the independent association of PTSD and medication adherence.
There are several potential explanations for why we found an association between PTSD and
adherence that was independent of depression, whereas others have not. The severity of
PTSD may have been higher in this VA population as compared to other samples.[35] In
addition, we used the gold-standard psychiatric interview to identify PTSD whereas prior
studies utilized briefer survey measures or interviews. This may have led to more accurate
PTSD categorization and more clear delineation between depression and PTSD in our
sample.
Currently, most plausible mechanisms to explain how PTSD may influence medication
adherence are rooted in PTSD-specific cognitive and behavioral symptoms. Avoidant
symptoms are one of the hallmarks of PTSD and patients with PTSD may not adhere to
medical treatments that remind them of their initial trauma or of their own mortality more
generally.15 Also, prior work has demonstrated that patients with PTSD may have
impairments in cognitive function, 37,38 and cognitive dysfunction has been linked with
medication non-adherence in prior studies.[36] Interestingly, nearly 41% of patients with
PTSD reported regularly forgetting their medications in our study. Accordingly, PTSD-
related deficits in cognitive function may lead to increased unintentional non-adherence.
Compared to non-adherence due to forgetting medications, we found an even stronger
association between PTSD and skipping medications. As described above, this could relate
to avoidance symptoms in patients with PTSD. However, it is also possible that patients
with PTSD after stroke have unfavorable illness beliefs that, in turn, lead to decreased
medication adherence.[37, 38] For example, PTSD has been associated with a sense of
foreshortened future[39, 40] and a lack of personal control over the illness that triggered
PTSD[41]; these distinct illness representations may lead affected patients to miss
preventive medications out of a fatalistic sense that such medications are not worth taking,
particularly for asymptomatic conditions like hypertension or hyperlipidemia. Although
some researchers have begun to look at the association between PTSD and beliefs about
PTSD treatment[42], we could find no published studies that explored beliefs about
treatment for medical conditions in patients with PTSD.
Our findings should be interpreted in light of several potential limitations. First, the cross-
sectional nature of the data prevents us from ascribing causal attributions to the association
of PTSD and medication adherence, though reverse causality (medication non-adherence
causing PTSD) is less plausible. Second, medication adherence was measured using self-
report and no objective measures of adherence were available to confirm responses.
Nevertheless, self-report measures are often highly correlated with objective measures[43]
and have been reliable predictors of poor outcomes in multiple studies.[44, 45] If anything,
self-reports may have underestimated the true prevalence of non-adherence in these patients.
[46] Third, the study population was majority men and was recruited from VA medical
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centers, which may reduce generalizability. Nevertheless, patients in this study were
recruited from general outpatient clinics and included patients with PTSD from a variety of
causes. Hence, this study broadens the literature pertaining to the association of PTSD and
medication adherence that has previously been restricted to disease-specific or trauma-
specific populations.
Summary/Conclusions
The results of this study suggest that PTSD may be putting patients at increased risk for
adverse outcomes from comorbid medical conditions as a result of decreased medication
adherence. As depression, socioeconomic status, and medical comorbidities did not explain
these associations, future studies should explore other mechanisms, such as differences in
beliefs about medications or cognitive dysfunction. In the meantime, clinicians should
carefully assess for adherence problems in patients with PTSD.
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Percentage of Patients With and Without Post-Traumatic Stress Disorder Who Are Non-
Adherent to Medications
Abbreviations: PTSD, Post-Traumatic Stress Disorder
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Table 1
Characteristics of 724 Study Patients According to Post-Traumatic Stress Disorder Diagnosis
Characteristic No Current PTSD N=473 Current PTSD N=251 P value
Demographics
 Age, mean (SD), in years 58.7 (12.0) 57.9 (10.2) 0.57
 Female sex 14 (3.0) 26 (10.4) <0.001
 White race 272 (58.2) 149 (61.1) 0.47
 Annual income < $20,000 157 (33.4) 71 (28.4) 0.17
 College graduate 143 (30.3) 71 (28.3) 0.57
Psychosocial
 Depression (PHQ-9 ≥ 10) 70 (14.8) 150 (59.8) <0.001
 MSPSS social support score, mean (SD) 43.5 (12.2) 36.5 (12.5) <0.001
 At-risk alcohol use (AUDIT-C ≥ 3 in women, ≥ 4 in men) 207 (44.7) 88 (36.4) 0.03
Medical History
 Hypercholesterolemia 233 (49.4) 144 (57.4) 0.04
 Hypertension 222 (46.9) 149 (59.4) 0.001
 Chronic obstructive pulmonary disease 77 (16.3) 57 (22.7) 0.03
 Diabetes mellitus 73 (15.4) 55 (21.9) 0.03
 Prior heart attack 41 (8.7) 35 (13.9) 0.03
Abbreviations: PTSD, Post-Traumatic Stress Disorder; MSPSS, Multidimensional Scale of Perceived Social Support; PHQ-9, 9-item Patient
Health Questionnaire; AUDIT-C, Alcohol Use Disorders Identification Test consumption questions
*
Data are presented as number (%) unless otherwise specified
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